Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 4,301–4,325 of 27,380 studies, newest first · page 173 of 1096.

May 2025 25

  1. 2025-05-15

    Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: In DDI (n = 431), participants were classified as CN A-/T- (n = 169), A+/T- (CN = 26, MCI = 24), A+/T+ (CN = 40, MCI = 105), and A-/T+ (CN = 34, MCI = 33), with a mean age of 64.1 years and 55.9% female. +1 more finding

  2. 2025-05-14

    Modifiable risk factors for stroke, dementia and late-life depression: a systematic review and DALY-weighted risk factors for a composite outcome

    ✓ Peer-reviewed Risk factors Journal of neurology, neurosurgery, and psychiatry

    Key finding: Our search yielded 182 meta-analyses meeting the inclusion criteria, of which 59 were selected to calculate DALY-weighted risk factors for a composite outcome. +4 more findings

  3. 2025-05-14

    Plasma neurofilament light chain mediates the effect of subsyndromal symptomatic depression on cognitive decline in older adults

    ✓ Peer-reviewed Biomarkers Frontiers in aging neuroscience

    Key finding: Participants with SSD exhibited a greater increase in plasma NfL levels and more pronounced declines in global cognition, memory, executive function, language, and processing speed over 2 years compared to non-SSD participants. +3 more findings

  4. 2025-05-14

    Using scores from the 4AT delirium detection tool as an indicator of possible dementia: a study of 75 221 older adult hospital admissions

    ✓ Peer-reviewed Clinical safety Age and Ageing

    Key finding: Of 75 221 admissions, 62 188 (82.7%; 33 625 unique patients; mean age 80.2 years; 55.8% female) had a 4AT on admission. +3 more findings

  5. 2025-05-14

    Targeting brain health in subjective cognitive decline: insights from a multidomain randomized controlled trial

    ✓ Peer-reviewed Prevention trials Aging Clinical and Experimental Research

    Key finding: The MI group significantly improved in attention-executive functioning (p = 0.003) compared to ACI (Cohen's d: 0.47, 95% CI 0.13-0.79). +4 more findings

  6. 2025-05-14

    Mechanical stimulation prevents impairment of axon growth and overcompensates microtubule destabilization in cellular models of Alzheimer’s disease and related Tau pathologies

    ✓ Peer-reviewed Disease mechanisms Frontiers in Medicine

    Key finding: We recently demonstrated that low mechanical forces promote MT stabilization, which in turn promotes axon growth and neuronal maturation. +1 more finding

  7. 2025-05-14
  8. 2025-05-14

    Improved dementia screening for elderly with low education in South Korea using the Cognitive Impairment Screening Test (CIST)

    ✓ Peer-reviewed Cognitive tests and assessment Frontiers in Neuroscience

    Key finding: When distinguishing NC from MCI/DM, the CIST outperformed the K-MMSE, demonstrating a higher AUC (0.869 vs. 0.842) and F1-score (0.697 vs. 0.409). +2 more findings

  9. 2025-05-14

    Application of Upper Limb Multimodal Tasks Combined With fNIRS Technology in the Assessment of Mild Cognitive Impairment

    ✓ Peer-reviewed Mild cognitive impairment Journal of Biophotonics

    Key finding: Mild cognitive impairment (MCI) is primarily characterized by a gradual decline in cognitive function, where early detection and intervention are crucial to preventing Alzheimer's disease progression. +2 more findings

  10. 2025-05-14

    Machine Learning for Predicting Postoperative Functional Disability and Mortality Among Older Patients With Cancer: Retrospective Cohort Study

    ✓ Peer-reviewed Digital health tools JMIR Aging

    Key finding: This study included 33,355 patients in the training, 14,294 in the internal validation, and 6711 in the external validation sets. +4 more findings

  11. 2025-05-14

    Understanding barriers and optimizing socio‐cognitive assessment in the diagnosis of neurocognitive disorders

    ✓ Peer-reviewed Getting a diagnosis Journal of Neuropsychology

    Key finding: Seventy-eight (78) % of respondents reported no/limited experience with socio-cognitive measures; more than 85% agreed on their relevance in clinics. +4 more findings

  12. 2025-05-13

    Mouse models of Anti-Aβ immunotherapies

    ✓ Peer-reviewed Treatments Molecular neurodegeneration

    Key finding: This review considers the use of these mouse models in understanding the mechanisms of Aβ clearance, cerebral amyloid angiopathy (CAA), blood brain barrier breakdown, neuroinflammation, and neuronal dysfunction in response to Aβ immunotherapy.

  13. 2025-05-13

    Patients With Moderate to Severe Dementia Who Undergo Elective TKA Face Elevated Risks of Death, Delirium, and Intensive Interventions: A Large, Propensity-weighted Database Study

    ✓ Peer-reviewed Clinical safety Clinical Orthopaedics and Related Research

    Key finding: After adjusting for potentially confounding variables such as age, gender, and comorbidities, we found that individuals with mild dementia (HR 1.74 [95% confidence interval (CI) 1.12 to 2.70]; p = 0.01) and moderate to severe dementia (HR 3.05 [95% CI 1.80 to 5.17]; p < 0.001) both demonstrated elevated hazards of death compared with patients without dementia. +4 more findings

  14. 2025-05-13
  15. 2025-05-13

    The Role of Tau in Neuronal Function and Neurodegeneration

    ✓ Peer-reviewed Disease mechanisms Neurology International

    Key finding: Other tauopathies, including Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Frontotemporal Dementia with Parkinsonism (FTDP-17), and Pick’s disease, are distinguished by the predominance of specific Tau isoforms (3R or 4R), cellular distribution, and affected brain regions. +4 more findings

  16. 2025-05-13

    Air pollution and Alzheimer disease phenotype deplete esterified proresolving lipid mediator reserves in the brain

    ✓ Peer-reviewed Disease mechanisms JCI Insight

    Key finding: It is unknown whether these deficits are due to reductions in esterified lipid pools, the main source of free bioactive proresolving lipids in the brain, and whether they are related AD pathophysiology.METHODSThis unknown was tested by measuring brain esterified lipid mediators and pathogenic markers of AD in TgF344-AD and WT male and female rats exposed to filtered air or TRAP for 14 months; it was also tested in human postmortem prefrontal cortex of individuals with or without AD.RESULTSSignificant reductions in proresolving lipid mediators esterified to neutral lipids and/or phospholipids were seen in AD and TRAP-exposed female rats, where levels were associated with inflammation, synaptic loss, and impaired glucose metabolism. +1 more finding

  17. 2025-05-13

    pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model

    ✓ Peer-reviewed Disease mechanisms npj Vaccines

    Key finding: Here we report the characterization and comparison of two additional Qβ VLP-based vaccines targeting the dual phosphorylation sites Ser199/Ser202 (Qβ-AT8) and Ser396/Ser404 (Qβ-PHF1). +4 more findings

  18. 2025-05-13

    Linking oxysterols and different stages of mild cognitive impairment: insights from gut metabolites and N6-methyladenosine

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer s Research & Therapy

    Key finding: EMCIs and LMCIs, especially LMCIs, exhibited poorer performance in almost all global and multidimensional cognitive tests. +4 more findings

  19. 2025-05-13

    Leveraging explainable artificial intelligence with ensemble of deep learning model for dementia prediction to enhance clinical decision support systems

    ✓ Peer-reviewed Digital health tools Scientific Reports

    Key finding: For the classification process, the proposed LXAIOA-ADPCM model implements ensemble classifiers such as the bidirectional long short-term memory (BiLSTM), sparse autoencoder (SAE), and temporal convolutional network (TCN) techniques. +4 more findings

  20. 2025-05-13

    Predicting dementia in people with Parkinson’s disease

    ✓ Peer-reviewed How common it is npj Parkinson s Disease

    Key finding: We concluded that genetic predisposition is the dominant factor, with significant influence from comorbidities. +1 more finding

  21. 2025-05-13
  22. 2025-05-13

    Early Detection of Alzheimers Disease Using Deep Learning

    ✓ Peer-reviewed Brain scans and imaging International Research Journal on Advanced Engineering Hub (IRJAEH)

    Key finding: Alzheimer's Disease acts as a degenerative brain trauma that results in poor memory, alongside impairing mental functioning.

  23. 2025-05-13

    Automated remote longitudinal neuropsychological testing with the California Cognitive Assessment Battery

    ✓ Peer-reviewed Getting a diagnosis The Clinical Neuropsychologist

    Key finding: The CCAB showed acceptable to good concurrent validity (rs = 0.44-0.79) and reliability (rs = 0.57-0.84). +4 more findings

  24. 2025-05-13

    A synthesis review of four literature reviews of disaster risk reduction education for children

    ✓ Peer-reviewed Prevention and risk International Journal of Disaster Risk Reduction

    Key finding: Program effectiveness was largely self-reported on an individual study-by-study basis across the wide diversity of programmatic elements represented. +4 more findings

  25. 2025-05-13

    Assessing disaster vulnerability and proposing an adaptive disaster risk reduction framework: the case of Istanbul

    ✓ Peer-reviewed Prevention and risk Natural Hazards

    Key finding: The findings support Istanbul's resilience and offer valuable guidance for urban planning and disaster management, both locally and globally.

Browse the library by subject, with the full score breakdown →